Clinical features of autoimmune hepatitis and primary biliary cholangitis: A comparative analysis
-
摘要:
目的比较自身免疫性肝炎(AIH)、原发性胆汁性胆管炎(PBC)临床特征,以利于两者的鉴别及早期诊断。方法收集2010年1月-2018年2月华中科技大学同济医学院附属协和医院诊治的AIH患者(n=83)和PBC患者(n=108)临床资料,包括年龄、性别、血清生化、免疫学指标及肝脏病理学检查结果,比较AIH与PBC的不同特征。正态分布计量资料两组间比较采用独立样本t检验;偏态分布计量资料两组间比较采用Mann-Whitney U检验。计数资料两组间比较采用X2检验或Fisher确切概率法。结果纳入AIH及PBC患者均以女性为主,发病年龄高峰为40~60岁。二者临床表现无明显特异性,主要症状体征均为:乏力、腹胀、黄疸、纳差,其中AIH组纳差患者比例明显高于PBC组(25%vs 14%,X2=6. 52,P=0. 011)。此外,AIH组肝硬化及合并风湿性疾病的比例亦明显高于PBC组(59. 0%vs 40. 7%,X2=6. 23,P=0. 012; 23. 5%vs 15. 7%,X2=7. 46,P=...
Abstract:Objective To compare the clinical features of autoimmune hepatitis ( AIH) and primary biliary cholangitis ( PBC) , and to provide a reference for differentiation and early diagnosis of these two diseases. Methods A retrospective analysis was performed for the clinical data of 83 patients with AIH and 108 patients with PBC who were diagnosed and treated in Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology from January 2010 to February 2018, including age, sex, serum biochemical parameters, immunological indices, and liver pathology. The clinical features of AIH and PBC were compared. The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of continuous data with skewed distribution between two groups; the chi-square test or the Fisher's exact test was used for comparison of categorical data between two groups. Results Most of the patients with AIH or PBC were female, with a peak age of onset of 40-60 years. There was no obvious specificity in the clinical features of AIH or PBC, with cardinal symptoms and signs of weakness, abdominal distension, jaundice, and poor appetite, and compared with the PBC group, the AIH group had a significantly higher proportion of patients with poor appetite ( 25% vs 14%, X2= 6. 52, P = 0. 011) . Compared with the PBC group, the AIH group also had significantly higher proportions of patients with liver cirrhosis ( 59. 0% vs 40. 7%, X2= 6. 23, P = 0. 012) and rheumatic diseases ( 23. 5% vs 15. 7%, X2= 7. 46, P = 0. 006) . Compared with the PBC group, the AIH group had significantly lower platelet count ( PLT) , alkaline phosphatase ( ALP) , gamma-glutamyl transpeptidase ( GGT) , immunoglobulin M, erythrocyte sedimentation rate ( ESR) , and complement C3 and significantly higher prothrombin time ( PT) , international normalized ratio ( INR) , and immunoglobulin G ( all P < 0. 05) . Compared with the AIH group, the PBC group had significantly higher positive rates of anti-mitochondrial antibody M2 ( 78. 8% vs 14. 8%, X2= 74. 70, P<0. 001) , anti-gp210 antibody ( 46. 4% vs 5. 3%, X2= 7. 31, P = 0. 007) , and anti-BCOADC-E2 PDC-E2 OGDC-E2 ( anti-3 E-BPO) antibodies ( 75. 0% vs 31. 6%, X2= 8. 73, P = 0. 003) . As for liver histological features, PBC was characterized by bile duct injury, including small cholangitis, biliary granuloma, absence of bile duct, and reactive hyperplasia of bile capillaries, while AIH was characterized by interface hepatitis ( X2= 31. 00 and 5. 88, P < 0. 001 and P = 0. 015) . Conclusion AIH and PBC often occur in women and lack specific clinical manifestations. PLT, ALP, GGT, PT, INR, ESR, complement, and immunoglobulins on admission, type of serological antibodies, and liver pathological features can be used for the differential diagnosis of AIH and PBC, and anti-3 E-BPO antibody can help with the diagnosis of PBC.
-
Key words:
- hepatitis, autoimmune /
- primary biliary cholangitis /
- disease attributes
-
[1]GATSELIS NK, ZACHOU K, KOUKOULIS GK, et al.Autoimmune hepatitis, one disease with many faces:Etiopathogenetic, clinico-laboratory and histological characteristics[J].World J Gastroenterol, 2015, 21 (1) :60-83. [2]LIU YW, YANG S, CEHNG J.Extrahepatic autoimmune diseases in primary biliary cholangitis[J/CD].Chin J Liver Dis:Electr Version, 2017, 9 (4) :27-30. (in Chinese) 刘雨薇, 杨松, 成军.原发性胆汁性胆管炎合并肝外自身免疫性疾病研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (4) :27-30. [3]HENNES EM, ZENIYA M, CZAJA AJ, et al.Simplified criteria for the diagnosis of autoimmune hepatitis[J].Hepatology, 2008, 48 (1) :169-176. [4]QIU D, WANG Q, WANG H, et al.Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients[J].J Hepatol, 2011, 54 (2) :340-347. [5]HEATHCOTE EJ.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guidelines[J].Hepatology, 2000, 31 (4) :1005-1013. [6]LINDOR KD, GERSHWIN ME, POUPON R, et al.Primary biliary cirrhosis[J].Hepatology, 2009, 50 (1) :291-308. [7]European Association for the Study of the Liver.EASL clinical practice guidelines:Management of cholestatic liver diseases[J].J Hepatol, 2009, 51 (2) :237-267. [8]Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.The programme of prevention and cure for viral hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62. [9]GORDON V, ADHIKARY R, APPLEBY V, et al.Diagnosis, presentation and initial severity of Autoimmune Hepatitis (AIH) in patients attending 28 hospitals in the UK[J].Liver Int, 2018, 38 (9) :1686-1695. [10]CORPECHOT C, CHAZOUILLRES O, ROUSSEAU A, et al.A placebo-controlled trial of bezafibrate in primary biliary cholangitis[J].N Engl J Med, 2018, 378 (23) :2171-2181. [11]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis) (2015) [J].J Clin Hepatol, 2015, 31 (12) :1980-1988. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.原发性胆汁性肝硬化 (又名原发性胆汁性胆管炎) 诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2015, 31 (12) :1980-1988. [12]GRANITO A, MURATORI P, MURATORI L, et al.Antinuclear antibodies giving the'multiple nuclear dots'or the'rim-like/membranous'patterns:Diagnostic accuracy for primary biliary cirrhosis[J].Aliment Pharmacol Ther, 2006, 24 (11-12) :1575-1583. [13]CHEN Y, HAN Y.Clinical features of primary biliary cholangitis and stratified treatment management[J].J Clin Hepatol, 2017, 33 (11) :2095-2100. (in Chinese) 陈瑜, 韩英.原发性胆汁性胆管炎的临床特征与治疗分层管理[J].临床肝胆病杂志, 2017, 33 (11) :2095-2100. [14]HE LF, LAI YJ, LAI LY, et al.Clinical features of patients with primary biliary cirrhosis[J].J Cent South Univ:Med Sci, 2015, 40 (12) :1333-1339. (in Chinese) 何丽芬, 赖伊杰, 赖力英, 等.原发性胆汁性肝硬化的临床特点[J].中南大学学报:医学版, 2015, 40 (12) :1333-1339. [15]JIANG XH, ZHONG RQ, YU SQ, et al.Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis[J].World JGastroenterol, 2003, 9 (6) :1352-1355. [16]DUAN WJ, OU XJ, MA H, et al.Diagnostic value and clinical significance of anti-sp100 and anti-gp210 in patients with primary biliary cholangitis[J].J Clin Exp Med, 2018, 17 (15) :1579-1581. (in Chinese) 段维佳, 欧晓娟, 马红, 等.抗sp100和抗gp210在原发性胆汁性胆管炎中的诊断和临床意义[J].临床和实验医学杂志, 2018, 17 (15) :1579-1581. [17]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of autoimmune hepatitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :9-22. [18]CZAJA AJ, CARPENTER HA.Autoimmune hepatitis with incidental histologic features of bile duct injury[J].Hepatology, 2001, 34 (4 Pt 1) :659-665.
计量
- 文章访问数: 2550
- HTML全文浏览量: 62
- PDF下载量: 366
- 被引次数: 0